Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Medical Spa Expert Dr. Alonso Martin Joins Exclusive Haute Beauty Network


News Image

A personalized approach is used to develop each client’s wellness program that may include the anti-aging and brain peptide, Emsculpt Neo, and facial rejuvenation.

Alonso Martin, MD is a board-certified physician focused on the results obtained when art and innovation meet beauty and longevity. He started his career at UCLA as a neuroscientist, where he studied the effects of antioxidants on longevity. Today, his practice offers the latest in non-invasive facial and body rejuvenation. He is recognized for delivering youthful and natural results that make his clients feel extraordinary. His medical practice focuses on medical aesthetics and award-winning wellness treatments that prevent muscle and bone loss.

He created the AM Longevity Method, a compilation of wellness principles and applications combined with Emsculpt Neo, an award-winning technology that grows new muscles and eliminates visceral fat. This technology is used by NFL athletes and many A-list celebrities for health optimization, strength, and longevity. For those looking to improve their sexual performance, he offers Emsella, a non-invasive treatment to improve sexual function and urinary incontinence.

Prior to opening his own practice, Dr. Martin worked as a primary care doctor treating age-related diseases such as obesity, high cholesterol, diabetes, depression, anxiety, hormone disorders, high blood pressure, chronic pain as well as autoimmune conditions. As non-invasive aesthetic treatments began emerging in the early 2000s, he was naturally drawn to this innovative field. In 2013, he trained with the American Association of Aesthetic Medicine and Surgery in Beverly Hills, an experience that changed his life forever. From then onward, he committed to additional years of injectable training and changed his focus from pharmaceutical treatments to prevention and wellness.

His area of expertise includes cosmetic dermatology with a focus on injectable neuromodulators (Botox, Daxxify, Dysport, Xeomin) and fillers. In addition, he offers 100% natural skin rejuvenation using PRF (Platelet-Rich Fibrin), a regenerative product obtained from the patient’s own blood. PRF rejuvenates the skin, stimulates collagen production, and reduces signs of aging such as wrinkles, fine lines, sun damage, and loose skin. His longevity practice includes the use of peptide therapy, also known as “strings of amino acids” that act as the building blocks for essential proteins in your body. A personalized approach is used to develop each client’s wellness program that may include the anti-aging and brain peptide, Emsculpt Neo, and facial rejuvenation.

We provide white glove aesthetic and wellness treatments. Today, his practice offers the latest modalities in non-invasive facial and body rejuvenation as well as longevity treatments with Emsculpt Neo, infrared light, cryotherapy, and PRF (platelet-rich fibrin). His practice will continue to add the latest in bio-optimization technologies that are safe and validated by science. Our medical concierge is always available via telemedicine for our limited clientele worldwide.

Dr. Martin earned his MD degree from Michigan State University and holds a B.Sc. in Neuroscience from UCLA. He trained at the University of California, Irvine Hospital in Family Medicine, where he treated patients of all ages. He is licensed in Florida and California and meets with clients in Miami Beach, FL, and Laguna Beach, CA. He is dedicated to philanthropy and is a contributing member of The Ronald McDonald House and other charitable organizations.

Learn more about Dr. Alonso Martin by visiting: https://hauteliving.com/hautebeauty/member/dr-alonso-martin/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Share article on social media or email:

Gravitas Medical Announces US FDA Clearance of the Entarik Platform


The Entarik System is designed to provide an alert when a nasogastric tube migrates so that ICU clinical staff can make timely decisions that assist in avoiding complications.

Gravitas Medical today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its innovative Entarik Feeding Tube System and Feeding Tube. This innovative enteral nutrition delivery system is set to be the first of many products that Gravitas will introduce that will transform enteral feeding into enteral intelligence. “Our mission is to use technology to replace the current nutrition delivery solutions with an enteral nutrition intelligence platform that helps caregivers make timely decisions for their patients, and this marks the beginning of that transformation,” said Saheel Sutaria, CEO of Gravitas Medical.

The system consists of a “smart” nasogastric tube equipped with sensors designed to provide information about the location of the tube tip relative to the stomach and a monitor that continuously monitors the position of the tube during the course of feeding. The system assists in reducing the incidence of misplacement during first positioning and provides real-time alerts of tube migration. “There is risk to the patient when a feeding tube migrates from the stomach to the esophagus,” said Sutaria. “The Entarik System is designed to provide an alert when a nasogastric tube migrates so that ICU clinical staff can make timely decisions that assist in avoiding complications.”

“We are thrilled to bring this innovative new product to market”, said Jim Gabalski, Vice President of Marketing and Sales. “The use of enteral feeding is rising as hospitals care for an increasing number of patients with head and neck cancer, stroke, and other conditions that inhibit normal food intake. Entarik provides an easy-to-use platform that will expand in capability to provide ICU teams with timely information, enabling better decisions, improved outcomes, and shorter lengths of stay.”

Gravitas Medical will be attending the American Society for Parenteral and Enteral Nutrition (ASPEN) Conference in Las Vegas on April 20-23, 2023 where interested Enteral Nutrition professionals will be able to get a first look at Entarik.

About Gravitas Medical

Gravitas Medical is a Silicon Valley-based medical device company that emerged out of Theranova, a MedTech incubator focused on tackling the biggest challenges in healthcare. Gravitas Medical is focused on transforming enteral feeding into enteral nutrition intelligence. The gut provides information and Gravitas uses use its passion for technology to find new ways to gather that information and provide it to caregivers so that they can make better decisions, improve outcomes for their patients, reduce the amount of time a patient stays in the hospital, and reduce the overall cost of care. They take the guesswork out of enteral nutrition.

Share article on social media or email:

American College of Lifestyle Medicine and National Board for Health & Wellness Coaching announce collaboration to advance the role of behavior change in health care


News Image

“Knowledge is important but, to achieve lasting behavior change, patients and clients also need coaching to motivate them and help them determine how to make and maintain lifestyle behavior changes to improve their health and wellbeing.”

The American College of Lifestyle Medicine (ACLM) and the National Board for Health & Wellness Coaching (NBHWC) have announced a strategic collaboration to advance behavior change and health and wellness coaching skills among health care professionals and enhance the role for health and wellness coaches on health care teams. The collaboration will provide an avenue for advancing research, education, and awareness to further uncover the benefits of coaching skills within the lifestyle medicine paradigm.

NBHWC, an affiliate of the National Board of Medical Examiners, provides board certification for health and wellness coaches. National Board Certified Health & Wellness Coaches (NBC-HWC) train in behavior change theories, motivational strategies, and health education and promotion theories. NBC-HWCs support clients in creating and sustaining change for improved health and well-being.

NBC-HWCs commonly work on health care teams alongside physicians and other clinicians as part of an integrative approach to patient and client care. Other NBC-HWCs work in digital health, community-based programs, or entrepreneurial capacities. NBHWC has board certified more than 8,400 health and wellness coaches.

ACLM and NBHWC are natural partners as many of the lifestyle behaviors that health and wellness coaches frequently address with patients and clients relate to the six pillars of lifestyle medicine—a whole food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connections. Lifestyle medicine is a medical specialty that uses therapeutic lifestyle interventions as a primary modality to treat chronic conditions including, but not limited to, cardiovascular diseases, type 2 diabetes, and obesity.

“Evidence-based lifestyle behavior interventions are proven to treat, prevent and even reverse many chronic conditions, but simply telling a patient or client what lifestyle changes to make is not enough,” said ACLM President and Harvard Medical School Clinical Assistant Professor Beth Frates, MD, FACLM, DipABLM, who also is a certified health coach. “Knowledge is important but, to achieve lasting behavior change, patients and clients also need coaching to motivate them and help them determine how to make and maintain lifestyle behavior changes to improve their health and wellbeing. ACLM is delighted to partner with the National Board for Health & Wellness Coaching to ensure that more clinicians develop health coaching skills, become board certified and bring awareness to the vital role of health coaches on care teams.”

Like health and wellness coaching, the specialty of lifestyle medicine is experiencing rapid growth. Since certification began in 2017 by the American Board of Lifestyle Medicine (ABLM), 2,445 physicians in the U.S. have become board certified in lifestyle medicine, along with 946 other health professionals. Globally across 72 nations, 3,999 physicians are now certified as well as 1,255 other health professionals.

The White House Conference on Hunger, Nutrition and Health in September highlighted lifestyle medicine and ACLM for its commitment to offer complimentary CME/CE coursework on lifestyle and food as medicine to 100,000 physicians and other health professionals. In addition to this introductory course for all clinicians, ACLM also offers a variety of other coursework, including NBHWC-approved continuing education courses for board certified health coaches.

In addition to the strategic collaboration with ACLM, NBHWC has joined ACLM as a member of the Corporate Roundtable, a group of organizations and companies united in a shared commitment to address the burden of chronic disease through novel products and solutions focused on health care transformation.

“The NBHWC sees tremendous value in joining ACLM as a strategic collaborator and member of the Corporate Roundtable, as we wish to align with leaders who believe in the power of partnering with patients and clients to support healthy lifestyle choices,” said NBHWC Executive Director Leigh-Ann Webster, NBC-HWC. “We believe that board certified health and wellness coaches play an integral role on the health care team, and we’re thrilled to be a part of a movement that will lead to improved health and well-being for all.”

ABOUT ACLM

The American College of Lifestyle Medicine is the nation’s medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based and equitable healthcare delivery system, leading to whole person health. ACLM educates, equips, empowers and supports its members through quality, evidence-based education, certification and research to identify and eradicate the root cause of chronic disease, with a clinical outcome goal of health restoration as opposed to disease management. http://www.lifestylemedicine.org

Share article on social media or email:

NEDHSA assists Grandfather in protecting and providing for his family with DD services


NEDHSA assists Grandfather in protecting and providing for his family with DD services

NEDHSA assists Grandfather in protecting and providing for his family with DD services

“Through talking on the phone, in-person visits, and communicating via email, Mr. Thornton and I work together to make sure Jordan is getting the services he needs,” Talley said.

Clint Thorton is a retired ceramic tile contractor, retired student teacher, and Director of Music at his church. After losing his wife to Huntington’s Disease, Thornton has spent his life as a single father of four children and, in recent years, a dedicated and compassionate grandfather who is the sole caretaker of his 23-year-old grandson Jordan Wilcockson.

Wilcockson was born handsome, healthy, and happy. However, the environment and conditions he was born into were incredibly unfit, causing extreme concern for Thorton. Wilcockson’s mother, Thorton’s daughter, has Huntington’s Disease, and in addition, Wilcockson grew up in a domestically abusive home. So much so that at two months old, Wilcockson became a victim of Shaken Baby Syndrome.

Victims of shaken baby syndrome vary with the severity of the injury. However, many cases are fatal or lead to severe neurological deficits such as Cerebral palsy, paralysis, vision loss or blindness, intellectual disability, epilepsy, or seizures. Parenthood is considered the biggest challenge in one’s life.

“It is hard for a single parent to raise children,” Thorton said. “But harder for a child in my grandson’s condition.”

Thorton did not let the foreseen struggles, complications, and financial strain deter him from protecting and providing for his grandson. The family’s relationship with Northeast Delta Human Services Authority (NEDHSA) began when Thorton received custody of Wilcockson when he was eight months old. Wilcockson’s diagnosis requires around-the-clock total care. Thorton loves his grandson and will do all he can, but there is only so much a grandfather can do alone; hence, NEDHSA services and resources were made available through Chasity Talley, Registered Nurse (RN).

“Mr. Thornton exemplifies what being an advocate for someone unable to speak for themselves genuinely means,” Talley said. “It is always such a pleasure to work with Mr. Clint Thornton.”

Talley, a NEDHSA Medical Certifications Specialist, works closely with the family to ensure needs are met by identifying areas of deficiencies, gaps in supplies, and any hindrances from comfortable daily living that allow Jordan to continue living in his family home.

“Through talking on the phone, in-person visits, and communicating via email, Mr. Thornton and I work together to make sure Jordan is getting the services he needs,” Talley said.

As a result of his ongoing and significant needs, Wilcockson was ruled eligible for the New Opportunities Waiver (NOW), which utilizes Medicaid funds to pay for much of his care. Through the NOW, the family can utilize private provider agencies or participate in Self-Direction Services for nursing services, individualized and family support services, environmental accessibility adaptations and any of the many other services available through this Waiver program.

At one point, Wilcockson’s care went from a combined 24 hours of nurse and personal care assistance staffing to four days a week, a total of 10 hours after moving from the city to a rural region. However, Talley was able to work with his support team and obtain approval for his personal care assistance back to 24 hours, lifting a significant burden on the family’s shoulders.

With the services and resources provided through NEDHSA, Thorton has hired and trained the direct support professionals to meet his grandson’s needs. The NOW also assists with funding for environmental modifications inside and outside of their home. With NEDHSA assistance in coordination and utilization of various funding sources including the NOW and Family Support funds, Wilcockson acquired a new wheelchair and personal care items when Medicaid funding no longer paid for those items.

“I know that neither my grandson nor I would have survived without 24-hour care, supplies, and God’s grace through it all,” Thorton said.

“Regardless of what services are needed all hands are on deck to assist in making sure that Jordan gets the services and care he needs to live his best life,” Talley said.

Share article on social media or email:

Recent Study Indicates Hospitals Excessively Transfuse Blood


Columbia Healthcare Analytics Logo

Columbia Healthcare Analytics Logo

“This study is valuable and timely to hospital systems around the globe. Transfusing blood from donors can transmit infections and can increase morbidity and death due to several other factors. Additionally, costs in healthcare and staffing needs are exacerbated by unnecessary treatments.”

Columbia Healthcare Analytics, Inc. released their recently published study results that indicate the need for additional education in blood transfusions.

According to a new retrospective sample 15-hospital clinical study published January 10th, 2023, in the Joint Commission Journal of Quality and Patient Safety (JCJQPS), as many as ninety-two percent of patients receiving a blood transfusion could likely receive much less blood. Forty-five percent of transfused patients could be adequately managed without any blood transfusion.

This study supports earlier findings and suggests a need for additional due diligence regarding blood transfusions.

Dr. David Jadwin, Founder and CEO of Columbia Healthcare Analytics, explains, “many contributing and recent factors include advances in patient blood management like hematinics (IV iron and erythropoietin) and pharmaceutical products that help control bleeding. Additionally, blood can be “salvaged” by collection and washing, after which doctors can return the patient’s blood rather than transfusing blood collected by local donor centers.”

The reported study attributes the high rate of avoidable transfusions to several physician-related factors.

For blood transfusion, the indications are typically based upon a laboratory value, commonly a hemoglobin value less than seven g/dL, or a “bleeding” indication. However, physicians are learning that patients can tolerate much lower hemoglobin values if adequately supported.Dr. Jadwin further states, “This study is valuable and timely to hospital systems around the globe.

Transfusing blood from donors can transmit infections, such as HIV and hepatitis, and can increase morbidity and death due to several other factors. Additionally, costs in healthcare and staffing needs are exacerbated by unnecessary treatments.”

This study will be used to appropriately educate physicians to use less blood.

To read the complete study, go to the following: https://www.jointcommissionjournal.com/article/S1553-7250(22)00246-X/fulltext

Columbia Healthcare Analytics, Inc. conducted this study. The results were partly verified using a panel of 10 independent physician reviewers.

About Columbia Healthcare Analytics, Inc.

Columbia Healthcare Analytics, Inc. has developed an anonymized medical review network that provides objective peer review, rapidly improving patient care. Our External Review as a Service (ERaaS™) technology ensures a standardized review that offers mentoring feedback for physicians. Anonymized patient care data for any medical care is analyzed in a HIPAA-compliant setting, which enables accurate regional and national performance measures. Our peer review network ensures that all participants are evaluated consistently and objectively and overcomes issues when physicians perform their own internal peer review. Gamification and incentives ensure optimal physician engagement and reward good patient management. ERaaS™ technology provides unsurpassed immediate and sustained patient care improvement.

Share article on social media or email:

Relapsing Polychondritis Foundation Renews Partnership with NYU Grossman School of Medicine to Invest in Next Phase of VEXAS Research


News Image

Because of the strong association between VEXAS and RP, we hope to fuel additional discoveries in the genetic causes of disease which will inevitably lead to new and better means of diagnoses and novel therapies.

The Relapsing Polychondritis (RP) Foundation is pleased to announce it will continue and expand its partnership with NYU Grossman School of Medicine to invest in and advance the next phase of collaborative VEXAS research.

Funding from the foundation not only contributed to the discovery of VEXAS syndrome, which pinpointed mutations in the UBA1 gene as the cause of the previously unknown inflammatory disease, but also helped produce valuable research including a recent study published in the Journal of the American Medical Association (JAMA) showing VEXAS to be more common than initially anticipated, afflicting approximately one in 4,000 men and one in 26,000 women over age 50.

David B. Beck, MD, PhD, assistant professor in the Department of Medicine and the Department of Biochemistry and Molecular Pharmacology at NYU Langone Health and director of NYU Langone’s clinical Inflammatory Disease Genetics Program, will continue to lead his laboratory and clinical program team with the aim of providing genetic diagnoses for individuals with unexplained, severe inflammatory disease, better understanding the mechanism of VEXAS syndrome, and finding treatments to help patients with VEXAS syndrome and RP, as more than half of patients with VEXAS meet diagnostic criteria for RP.

“We are thrilled to grow our partnership with the Relapsing Polychondritis Foundation. Support from the RP Foundation has fueled our discoveries to date, and we are both committed to improving outcomes for people suffering from VEXAS and related autoimmune diseases. We are grateful for the foundation’s efforts to educate the public about these diseases and raise funds to help find the causes as well as effective treatments,” said Dr. Beck.

“Because of the strong association between VEXAS and RP, we hope to fuel additional discoveries in the genetic causes of disease which will inevitably lead to new and better means of diagnoses and novel therapies. We are optimistic Dr. Beck and his team will continue to have a considerable impact on rheumatology, hematology, and autoimmune research through their work and are proud to be partnering with them for another chapter of our mutual mission,” said David Bammert, President of the RP Foundation.

For more information about relapsing polychondritis, the RP Foundation, and the Race for RP, please visit https://www.polychondritis.org and https://raceforrp.org. For all general and media inquiries, please contact David Bammert at (906) 869-3962 or dbammert@polychondritis.org.

About the Relapsing Polychondritis Foundation Inc.

The Relapsing Polychondritis Foundation Inc. is a 501(c)(3) non-profit organization which strives to raise awareness and educate the public, as well as represent its patients to the global medical community and support medical research toward a cure. For more information about the RP Foundation, please visit the foundation’s website.

About Race for RP

Race for RP is a non-profit organization that supports research, awareness programs, and care, for those affected by relapsing polychondritis and related diseases. RP is a painful, debilitating, and sometimes fatal autoimmune disease in which the immune system misfires, turning on the patient’s cartilage. For more information about Race for RP, please visit the organization’s website.

Media Contacts:

Company Name: Relapsing Polychondritis Foundation

Name: David Bammert

Phone: (906) 869-3962

Email Address: Send Email

Website: https://www.polychondritis.org

Share article on social media or email:

Inbound Health Exceeds 5,000 Acute Care-at-Home Episodes in its Partnership with Allina Health


News Image

…Inbound Health brings the capabilities and experience to help our partners address real problems including challenges with inpatient capacity, length of stay increases due to post-acute care bed availability, the total cost of care, and patient experience…

Inbound Health, a company that enables health systems and health plans to offer hospital-at-home and skilled nursing-at-home programs, has announced today that their proprietary platform has enabled Allina Health to successfully conduct over 5,000 home-based acute care episodes. Data generated from the 5,000+ historical episodes show that Allina Health is caring for patients with high severity of illness yet achieving outsized clinical outcomes. Since the program’s inception, the average severity of illness score for the home hospital cohort of patients was 24.3% higher than that of the cohort of patients that were referred to a facility-based care setting. At the same time, the program generated a potentially preventable readmissions score of .91, outperforming brick-and-mortar post-acute care settings. The program has generated an average NPS score of 86, demonstrating that patients and their family members prefer this level of care when clinically appropriate.

Through this partnership, Inbound Health provides a wide complement of capabilities required to power this innovative level of care that include home-based care pathways, virtual care teams, engagement and workflow technology, analytics, supply chain partnerships, logistical oversight, and payer contracting. Allina Health has leveraged this program to manage a wider swath of the continuum of care for its patients, thereby ensuring that care is delivered in a safe, coordinated, and patient-centric manner. The company combines biometric monitoring, digital surveillance, in-home nursing and therapy, virtual visits with hospitalists and geriatricians, and a comprehensive supply chain to deliver a safe and high-quality care program. The company’s flexible partnership structure enables Allina Health to leverage its existing assets and capabilities while relying on Inbound Health to fill the gaps required to scale these programs across its service area.

“Allina Heath’s home hospital program represents a new level of care – one that provides safe and high-quality care in a more comfortable setting at a lower cost,” said Emily Downing, Allina Health’s Chief Clinical Officer for Population Health. “Our partnership with Inbound Health will enable us to offer Home Hospital Care to more patients throughout Minnesota and to continue to enhance care and service offerings for our Home Hospital care patients. We are excited for what lies ahead of us in this important partnership.”

Inbound Health has proven that the program lowers the total cost-of-care by 30-40% on a risk-adjusted basis while achieving similar or improved clinical outcomes when compared to traditional facility-based care. These outcomes have enabled Inbound Health and Allina Health to develop unique episodic-based payer contracts with multiple Commercial and Medicare Advantage payers in Minnesota, a payment model that the company plans on replicating with partners in other markets.

Blue Cross and Blue Shield of Minnesota was an early supporter of Inbound Health through its network agreement with Allina Health. “We are committed to advancing emerging care models to improve the patient experience and lower the total cost of care,” said Eric Hoag, Vice President of Provider Relations at Blue Cross. “We continue to be excited about offering this new level of care to our members when clinically appropriate and look forward to ongoing collaboration as the model is expanded.”

Inbound Health has successfully cared for patients across 350 different disease states. While the program was developed at the beginning of the COVID-19 pandemic, the vast majority of the patients they serve today, alongside Allina Health, are not COVID-positive. The company is in multiple discussions with other health systems and health plans in different parts of the United States and expects to launch in several new markets over the next year. In addition, over the next year Inbound Health is investing over $10 million in its proprietary technology and analytics platform, which has been developed based on the experience garnered over the past three years.

“We are very proud of the fact that our partnership with Allina Health has delivered safe and high-quality care at a lower total cost,” said Dave Kerwar, CEO of Inbound Health. “Inbound Health brings the capabilities and experience to help our partners address real problems including challenges with inpatient capacity, length of stay increases due to post-acute care bed availability, the total cost of care, and patient experience. We are particularly proud of the fact that alongside Allina Health, we are increasing not just the volume of patients served but also the variety of disease states and referral settings. Over the past year, non-covid admissions have increased by 80%, and admissions from the Emergency Department have grown by 10%. These results demonstrate Inbound’s ability to support scaling health system programs and indicate a strong outlook for hospital-at-home beyond the typical COVID use case.”

To learn more, visit http://www.inboundhealth.com.

About Inbound Health

Inbound Health provides a full stack of capabilities that enables health systems and health plans to offer hospital and skilled nursing facility-level care in the home. With a commitment to quality and compassionate care, Inbound Health has treated over 5,000 patients across 350+ DRGs and counting, and will further customize the care model to the needs and strategies of its partners. Learn more at http://www.inboundhealth.com.

About Allina Health

Allina Health is dedicated to the prevention and treatment of illness and enhancing the greater health of individuals, families and communities throughout Minnesota and western Wisconsin. A not-for-profit health care system, Allina Health cares for patients from beginning to end-of-life through its 90+ clinics, 12 hospitals, 14 retail pharmacies, specialty care centers and specialty medical services that provide home care, senior transitions, hospice care, home oxygen and medical equipment, and emergency medical transportation services. Learn more at allinahealth.org and join us on Facebook and Twitter.

Share article on social media or email:



SightMD Welcomes The Ophthalmic Center To Its Expert Team


News Image

“The founders of SightMD along with their entire organization, align with our clinical mission statement that “patients come first”. Together we are looking forward to continuing our mission and expertise in the greater Long Island area.” said Dr. Basilice

SightMD, a leading multi-specialty ophthalmology platform, today announced a strategic partnership with The Ophthalmic Center (TOC Eye), an eastern Long Island based ophthalmology practice. Through this strategic partnership the practices in East Setauket, 8 Technology Drive East Setauket, NY 11733 and in Wading River, 6144 Route 25A Wading River, NY 11792 will expand SightMD’s presence by adding two location and four providers, growing SightMD’s current footprint to 40+ locations and 85+ providers across New York.

For over 40 years, TOC Eye has been a preferred ophthalmology practice for individuals seeking vision correction and comprehensive eye care throughout eastern Long Island, NY. The talented eye surgeons and optometrists at TOC Eye strive to dramatically improve the quality of life for their patients in East Setauket and Wading River. Thousands of people have trusted their award-winning team with their families’ eye care and vision correction treatment, and we are grateful for the opportunity to have them join the expert team at SightMD. The doctors at TOC Eye joining the SightMD team are Vincent P. Basilice, MD, Michael Conners, MD, Alexander Llinas, MD, and Alex Schaffer, OD.

Jeffrey Martin, MD, Co-founder and President of SightMD, said, “I am honored to be partnering with the eye doctors of The Ophthalmic Center. Dr. Basilice is an excellent doctor who has enjoyed an amazing reputation over many years. I look forward to working together to provide the best in care to our patients”.

Jonathan Lujan, CEO of Sight Growth Partners added “Sight Growth Partners is privileged to have the opportunity to be the administrator for TOC Eye where all of the doctors and staff provide the highest quality of eye care to their patients.”

Dr. Basilice, the founder and medical director of TOC Eye, is a board-certified ophthalmologist that has been regarded as one of the best eye surgeons on Long Island for over 40 years. Dr. Basilice is regularly sought out as a community, organizational, and education speaker, addressing a diverse array of ophthalmic topics including glaucoma, macular degeneration, diabetic eye care, and the latest advances in cataract IOL treatment and laser vision correction. Dr. Basilice has been invited to participate in a number of clinical trials including investigation for the multifocal intraocular lens as well as numerous other pharmaceutical test protocols. In addition, Dr. Basilice is recognized as one of the Island’s foremost authorities on LASIK laser vision correction, being among the first on Long Island to regularly include the advanced technologies of WaveScan pre-surgical testing and the capabilities of the VISX Star S4 excimer laser. Dr. Basilice is a Castle Connolly Top Doctor. He received the prestigious Theodore Roosevelt Award and was recognized as The Humanitarian Of The Year in 2015. Dr. Basilice is a Brooklyn native and now resides with his wife Dahna in Suffolk County. Dr. Basilice has stated his excitement to start this new chapter of his medical career with SightMD. When asked about how he feels about joining SightMD Dr. Basilice said “The founders of SightMD along with their entire organization, align with our clinical mission statement that “patients come first”. Together we are looking forward to continuing our mission and expertise in the greater Long Island area.”

Dr. Conners is a Board Certified Ophthalmologist, who brings expertise in the fields of Cornea and External Diseases as well as Refractive Surgery. Dr. Conners is a graduate of Hofstra University and completed his medical and graduate training at New York Medical College resulting in a dual M.D., Ph.D. degree. Dr. Conners completed fellowship training in Cornea, External Diseases and Refractive Surgery both at Washington University and the nationally recognized Minnesota Eye Consultants in Minneapolis. Dr. Conners has extensive experience in routine and complex cataract surgery including the newer multifocal and accommodative lens technology. Dr. Conners is a Long Island native, having grown up in East Meadow and now residing in Miller Place with his wife and has 3 grown children.

Dr. Llinas specializes in the treatment of glaucoma both medically and surgically. His education has been quite extensive, receiving his Bachelor of Arts degree from New York University. He attended St. Andrews University, one of the oldest and most prestigious universities in the United Kingdom, where he received a Ph.D. in molecular biology. Dr. Llinas also received his Medical Doctorate from New York University School of Medicine in Manhattan. Although Dr. Llinas spends most of his time caring for his glaucoma patients, he still finds time to do research in the field. He has given many lectures to very diverse groups and continues to author papers on the subject of glaucoma. Dr. Llinas was born in Chicago, Illinois, but spent most of his life in Manhattan. He has since moved to Long Island, where he resides with his wife and his young children.

Dr. Schaffer earned his doctorate degree in optometry from SUNY Optometry in Manhattan. While obtaining his degree, Dr. Schaffer interned at TOC Eye, The Veterans Hospital in Northport, and at Family Vision Care in San Carlos, California. This training allowed him to work closely with both optometrists and ophthalmologists in treating diseases such as glaucoma and macular degeneration, in addition to fitting contact lenses and providing vision therapy and rehabilitative services to patients. Dr. Schaffer is a member of the American Optometric Association. He is a long time resident of Setauket and a graduate of Ward Melville High School. He is proud to call the Three Villages his home and hopes to provide continuing quality eye-care within the community. Dr. Schaffer resides in South Setauket with his wife, 2 young children and another on the way.

The team of doctors at TOC Eye will continue to care for their patients at the same Wading River and East Setauket offices. With this partnership their patients and the community will have access to seamless care at all of SightMD’s office locations throughout Long Island, Westchester and New York City.

About SightMD

SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 80 eye care providers through the convenience of 40 locations across New York. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include general eye exams, laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD as well as SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. For more information about SightMD, please visit https://www.sightmd.com/sightmd-ny/

About Sight Growth Partners

Sight Growth Partners is the leading administrative services provider for the ophthalmology sector including SightMD in New York, SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. It has over 140 employees who provide administrative solutions to physicians, ophthalmology clinics and ambulatory surgery centers. Sight Growth Partners provides its clients with world-class administrative services, including a 24/7 call center, billing, credentialing, marketing, human resources, and other services, enabling them to continue delivering best-in-class care to patients in their communities. Sight Growth Partners is backed by Chicago Pacific Founders, a leading middle market private equity firm which focuses exclusively on partnerships with growing companies in the healthcare services sector. For more information about Sight Growth Partners, please visit http://www.sightgrowthpartners.com.

CytoVeris and AdventHealth Central Florida Join Forces for Clinical Study to Improve Prostate Cancer Outcomes


News Image

CytoVeris Inc., a medical device company developing AI-powered cancer imaging technologies to enable more precise surgical decision-making and improve patient outcomes, today announced the start of a new clinical research study to investigate the precision of using an AI-powered imaging device during surgery to improve prostate cancer margin assessment. This device, called MarginASSURE, is expected to provide more precise surgical decision-making in real-time while also improving patient outcomes.

The study, a collaboration between CytoVeris Inc. and AdventHealth Central Florida, will focus on CytoVeris’ multispectral imaging capability for the intraoperative assessment of cancer margin during robotically assisted radical prostatectomy (RARP) surgery.

The study will only involve U.S.-based surgeries at the AdventHeath Celebration facility and will be led by Vipul Patel, M.D., founder and medical director of the Global Robotics Institute at AdventHealth Celebration, and his team. Patel is world-renowned for his contribution to the field of robotic-assisted surgery and is one of the most experienced robotic surgeons in the world, having personally performed over 16,000 robotic prostatectomies.

“We are very excited to extend our technology to help surgeons and their patients undergoing prostatectomy in collaboration with one of the world’s leading surgeons in Dr. Patel and the outstanding team at AdventHealth,” said Patrick Curry, COO of CytoVeris. “Having demonstrated the technology in bladder and breast cancer surgery, this is the next impactful indication for our platform.”

Why it matters:

According to the American Cancer Society, prostate cancer is second only to skin cancer among the most common cancers in American men. This year, it is estimated that the U.S. will see 288,300 new cases of prostate cancer resulting in 34,700 deaths. Among men diagnosed with prostate cancer this year, approximately 90,000 will undergo RARP surgery [1]. Post-surgical positive margin rates are generally only in the 20% range which can lead to complications and poorer patient outcomes [2].

How the device will be used in the study:

During the course of the multi-year study, Patel will collaborate with CytoVeris in adapting and developing its imaging platform for prostate cancer margin assessment.

“In the operating room, every move is critical. Robotic devices are changing the way we (surgeons) operate by providing more precision, therefore better patient outcomes,” Patel said. “This study will attempt to demonstrate the capability of MarginASSURE and its ability to detect cancer in near-real time in a label-free manner through the development of advanced tissue characterization technologies that can identify cancer tissue, assess margins, and identify critical tissue structures.”

The CytoVeris system is based on proprietary Multi-Spectral Tissue Auto-Fluorescence (AF) Imaging technology that analyzes the “optical fingerprint” of tissue due to its intrinsic biomolecular and morphological characteristics, without the use of dyes or imaging agents.

The prostate imaging device, named MarginASSURE, is designed to provide rapid margin assessment of excised prostate specimens and deliver to the surgeon actionable data to help guide the surgical steps required to better optimize patient outcomes, while also optimizing nerve sparing.

The project work will incorporate and correlate pre-operative MRI imaging of tumors with the MarginASSURE imaging of RARP specimens suspect of extraprostatic/extracapsular extension of cancer into the periprostatic soft tissues.

“CytoVeris was founded on the vision that, by leveraging advanced optical imaging and artificial intelligence, surgeons will have the ability to visualize cancer when it matters most – in the operating room,” said Dr. Alan D. Kersey, Ph.D., president & CEO of CytoVeris. “This clinical research study aims to demonstrate and validate our technology in prostate cancer, opening doors to further optimize patient outcomes.”

About CytoVeris:

Based in Farmington CT, CytoVeris is a medical device manufacturer developing AI-powered imaging technology for real-time ex-vivo tissue visualization and identification, enabling more precise intraoperative decisions, leading to improved patient outcomes and reducing unnecessary repeat procedures. Our intraoperative imaging platform, based on a proprietary Multi-Spectral Tissue Auto-Fluorescence Imaging (MS-TAFI) system and powered by AI-based machine learning algorithms, analyzes the “optical fingerprint” of the tissue corresponding to its intrinsic biomolecular and morphological characteristics, without the use of dyes or imaging agents.

For more information, visit http://www.cytoveris.com

About the AdventHealth Central Florida Division:

AdventHealth’s Central Florida Division encompasses more than 20 hospitals and ERs in the six counties in and surrounding metro Orlando. The world-class hospitals, combined with a comprehensive outpatient care network, see more than 5.7 million patient visits annually.

AdventHealth also has an expansive research portfolio in Central Florida, with more than 500 clinical trials and studies in progress.

The organization has a deep commitment to serving the community and has a local financial impact of more than $1 billion annually. AdventHealth and its employees are responsible for nearly 20 percent of Central Florida’s economy.

The division’s flagship campus — AdventHealth Orlando — boasts nationally and internationally recognized programs and serves as a major tertiary and quaternary referral hospital for much of the Southeast, the Caribbean and Latin America. Quality specialty care is provided through AdventHealth Institutes, which is nationally recognized in numerous specialties.

AdventHealth Orlando has been recognized by U.S. News & World Report, Newsweek, Centers for Medicare and Medicaid Services, and the Leapfrog Group.

Learn more about the Central Florida Division on our Newsroom.

REFERENCES:

1.    Underwood, W., III, Jackson, J., Wei, J.T., Dunn, R., Baker, E., DeMonner, S. and Wood, D.P. (2005), Racial treatment trends in localized/regional prostate carcinoma: 1992–1999. Cancer, 103: 538-545. https://doi.org/10.1002/cncr.20796

2.     Iczkowski KA, Lucia MS. Frequency of positive surgical margin at prostatectomy and its effect on patient outcome. Prostate Cancer. 2011;2011:673021. doi: 10.1155/2011/673021. Epub 2011 Jun 9. PMID: 22110996; PMCID: PMC3200270.

Professional Physical Therapy Announces New Clinic Opening in Cresskill, NJ


Professional Physical Therapy, a leading provider of outpatient physical therapy and rehabilitation services throughout New York, New Jersey, Connecticut, Massachusetts, and New Hampshire, announces the opening of a new clinic in Cresskill, NJ. The 3,000 square foot facility includes a large rehabilitation space with state-of-the-art equipment for patients.

The new clinic is located at 300 Knickerbocker Road, right across from the Camp Merritt Memorial circle at the intersection of Knickerbocker Road and Madison Avenue. It was opened under Professional’s strategic partnership program that provides a unique affiliation solution to clinicians and leaders who are vested in ownership and operations. Even more patients in New Jersey will have greater access to the clinical expertise and cutting-edge therapeutics offered by Professional.

The clinic will be led by Clinical Director Partner, Purvang Kapadia, PT, MS, DPT, OCS. Purvang is excited to open in Cresskill and adds, “I am thrilled to partner with Professional PT to bring expertise and a patient first attitude to Cresskill and help serve the local community to lead an active, pain free life. I look forward to providing an exceptional client experience and be part of a thriving culture.”

Services available at Professional Physical Therapy in the Cresskill clinic include:

  • Physical Therapy – Our physical therapists treat medical conditions that limit functional mobility and help develop a customized treatment plan to improve the ability to move, reduce pain, restore function, and prevent disability.
  • TMJ Therapy – If you are experiencing jaw pain our physical therapists can provide a treatment plan to strengthen and stretch the muscles in your face to reduce pain and discomfort.
  • Vestibular Therapy – We have specialists that can design an exercise-based treatment plan to help reduce feeling of vertigo or dizziness and improve balance and coordination.
  • Free Injury Screens – If you have an ache, pain, performance issue, or question, you can schedule a 1-on-1 session with one of our physical therapists. We evaluate your condition to help recommend which treatments may be effective, including making a referral if a specialist is advised.


Additionally, the Cresskill clinic:

  • Accepts most major insurance plans.
  • Offers convenient hours, including early mornings and late evenings.
  • Does not require a physician referral or prescription to start treatment.
  • Schedules each initial evaluation quickly, sometime the same or next day.
  • Provides ongoing patient education on diagnosis, treatment plans and prescribed home-exercise programs.


Professional Physical Therapy currently operates widely across five of the Northeast states. For more information and a list of all Professional Physical Therapy locations and services, please visit http://www.professionalpt.com

About Professional Physical Therapy

Professional Physical Therapy was founded in 1999 and is an industry leader, providing private outpatient physical and hand therapy services throughout the Northeast. Our clinical team is comprised of multi-specialty Physical, Hand and Occupational Therapists who can treat a wide variety of orthopedic injuries and conditions with excellence. Today, Professional has grown to include over 190 facilities in New York, New Jersey, Connecticut, Massachusetts, and New Hampshire.

Share article on social media or email: